Vancouver-based company plays role in Pfizer COVID-19 vaccine

  • 📰 VancouverSun
  • ⏱ Reading Time:
  • 14 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 61%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Acuitas Therapeutics based at the University of B.C. makes the delivery system for the new Pfizer/BioNTech vaccine for COVID\u002D19.

The B.C. government has announced that long-term care residents and health-care workers will be the first to receive the vaccine next week. The vaccine comes in two doses meant to be administered three weeks apart. After the first dose, the efficacy is about 52 per cent; after the second, 95 per cent.that the vaccine worked regardless of race, weight or age. No one experienced any serious side-effects in the trial of 43,661 people from around the world but many experienced aches and fevers.

Acuitas was founded in 2009 by Thomas Madden, the company president and CEO, and his longtime collaborator, Pieter Cullis, board chairman and scientific adviser. Madden said that it was humbling to realize that Acuitas has played a role in delivering a COVID-19 vaccine.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 49. in NG

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines